Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M167Revenue $M2.0Net Margin (%)-2,700.4Z-Score-3.1
Enterprise Value $M134EPS $-3.1Operating Margin %-2,640.6F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-2,700.4Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %0Quick Ratio17.5Cash flow > EarningsY
Price/Sales59.85-y EBITDA Growth Rate %0Current Ratio17.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-75.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-197.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M19.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ARGS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pharmstandard International S.10% Owner 2014-02-12Buy1,275,000$810.13 view
Underdown Brian J.Director, 10% Owner 2014-02-12Buy40,497$810.13 view
Cooperatieve AAC LS U.A.10% Owner 2014-02-12Buy36,416$810.13 view
Birner HubertDirector, 10% Owner 2014-02-12Buy39,873$810.13 view
van Deventer SanderDirector, 10% Owner 2014-02-12Buy36,416$810.13 view
Mizuho Capital No. 3 Limited P10% Owner 2014-02-06Sell0$010.13 view
Kyowa Hakko Kirin Co Ltd10% Owner 2014-02-06Sell0$010.13 view
TFG USA, LLC10% Owner 2014-02-06Sell0$010.13 view

Press Releases about ARGS :

    Quarterly/Annual Reports about ARGS:

      News about ARGS:

      Articles On GuruFocus.com
      Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

      More From Other Websites
      Argos Therapeutics Licenses Arcelis(R) Technology Platform to Lummy HK for Development of... Apr 14 2015
      Argos Therapeutics Licenses Arcelis(R) Technology Platform to Lummy HK for Development of... Apr 14 2015
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Apr 13 2015
      Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference Apr 07 2015
      Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference Apr 07 2015
      ARGOS THERAPEUTICS INC Financials Apr 04 2015
      NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing... Apr 01 2015
      NIH Funds Study of Fully Personalized Immunotherapy AGS-004 Combined With a Latency Reversing... Apr 01 2015
      ARGOS THERAPEUTICS INC Files SEC form 10-K, Annual Report Mar 31 2015
      Argos Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results Mar 30 2015
      Argos Therapeutics Inc Earnings Call scheduled for 4:30 pm ET today Mar 30 2015
      Argos Therapeutics reports 4Q loss Mar 30 2015
      Argos Therapeutics reports 4Q loss Mar 30 2015
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 30 2015
      Argos Therapeutics Reports Fourth Quarter and Year-End 2014 Financial Results Mar 30 2015
      Q4 2014 Argos Therapeutics Inc Earnings Release - After Market Close Mar 30 2015
      Coverage initiated on Argos Therapeutics by ROTH Capital Mar 26 2015
      Argos Therapeutics Director of Immunology to Present at HIV Vaccines Meeting Mar 20 2015
      Argos Therapeutics Director of Immunology to Present at HIV Vaccines Meeting Mar 20 2015
      Argos Therapeutics to Hold Fourth Quarter and Year-End 2014 Financial Results Conference Call on... Mar 16 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK